mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.2 |